Shuang Dai, Yingtong Liu, Zheran Liu, Ruidan Li, Feng Luo, Yan Li, . . . Xingchen Peng. (2024). Cancer-associated fibroblasts mediate resistance to anti-EGFR therapies in cancer. Elsevier.
Chicago Style (17th ed.) CitationShuang Dai, Yingtong Liu, Zheran Liu, Ruidan Li, Feng Luo, Yan Li, Lei Dai, and Xingchen Peng. Cancer-associated Fibroblasts Mediate Resistance to Anti-EGFR Therapies in Cancer. Elsevier, 2024.
MLA (9th ed.) CitationShuang Dai, et al. Cancer-associated Fibroblasts Mediate Resistance to Anti-EGFR Therapies in Cancer. Elsevier, 2024.
Warning: These citations may not always be 100% accurate.